The Technology Strategy Board, in partnership with the Department of Health, invites applications for its call to assess the impact of near-patient testing.
The competition aims to generate health economics capabilities and models that will assist companies in predicting the impact of the introduction of point-of-care diagnostics. Applicants may directly evaluate the impact of the introduction of CE marked products to collect data to inform their models. The CE marked products and models must be for a disease or condition prioritised by DH for the detection and identification of infectious agents programme.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.